Bio-Path Holdings Files 8-K on Financials
Ticker: BPTH · Form: 8-K · Filed: Nov 15, 2024 · CIK: 1133818
| Field | Detail |
|---|---|
| Company | Bio-Path Holdings, Inc. (BPTH) |
| Form Type | 8-K |
| Filed Date | Nov 15, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, results-of-operations
Related Tickers: BPTH
TL;DR
BPTH filed an 8-K, expect financial updates soon.
AI Summary
Bio-Path Holdings, Inc. filed an 8-K on November 15, 2024, reporting on its results of operations and financial condition, and including financial statements and exhibits. The filing does not contain specific financial figures or operational updates within the provided text, but indicates a formal reporting event.
Why It Matters
This filing signifies a routine update on Bio-Path Holdings' financial status and operational results, crucial for investors to assess the company's performance.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting financial condition and results of operations, not indicating any immediate material adverse events.
Key Players & Entities
- BIO-PATH HOLDINGS, INC. (company) — Registrant
- November 15, 2024 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- 4710 Bellaire Boulevard , Suite 210 , Bellaire , Texas 77401 (address) — Principal executive office address
FAQ
What specific financial results are being reported in this 8-K?
The provided text indicates the filing is for 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not detail the specific financial figures within this excerpt.
When was this 8-K filed?
This 8-K was filed on November 15, 2024.
What is the primary purpose of this 8-K filing for Bio-Path Holdings, Inc.?
The primary purpose is to report on the company's results of operations and financial condition, and to include financial statements and exhibits.
Where is Bio-Path Holdings, Inc. headquartered?
Bio-Path Holdings, Inc.'s principal executive offices are located at 4710 Bellaire Boulevard, Suite 210, Bellaire, Texas 77401.
What is the SIC code for Bio-Path Holdings, Inc.?
The Standard Industrial Classification (SIC) code for Bio-Path Holdings, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 550 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2024-11-15 07:30:32
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share BPTH The Nasdaq Capital M
Filing Documents
- bpth-20241115x8k.htm (8-K) — 40KB
- bpth-20241115xex99d1.htm (EX-99.1) — 31KB
- bpth-20241115xex99d1001.jpg (GRAPHIC) — 11KB
- 0001558370-24-015779.txt ( ) — 211KB
- bpth-20241115.xsd (EX-101.SCH) — 3KB
- bpth-20241115_lab.xml (EX-101.LAB) — 16KB
- bpth-20241115_pre.xml (EX-101.PRE) — 10KB
- bpth-20241115x8k_htm.xml (XML) — 5KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. The information in this Current Report on Form 8-K (this "Current Report") is being furnished pursuant to Item 2.02 of Form 8-K and, according to general instruction B.2. thereunder, the information in this Current Report shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in this Current Report shall not be incorporated by reference into any registration statement pursuant to the Securities Act of 1933, as amended. On November 15, 2024, Bio-Path Holdings, Inc. (the "Company") issued a press release announcing financial results for the quarter ended September 30, 2024. Additional information is included in the Company's press release. A copy of the Company's press release is attached hereto as Exhibit 99.1. The foregoing description of the press release is qualified in its entirety by reference to the attached exhibit.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits . Exhibit Number Description 99.1 Press release dated November 15, 2024. 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL (included as Exhibit 101).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized. BIO-PATH HOLDINGS, INC. Dated: November 15, 2024 By: /s/ Peter H. Nielsen Peter H. Nielsen President and Chief Executive Officer